Cancers in MSH6 carriers occur later in life than those with MLH1 and MSH2; the PMS2 gene is related to the lowest cumulative rate of tumors; EPCAM mutations are more often described in relationship with CRC rather than non-colonic neoplasia [5,8,9]. This evidence concerns the gene MSH2 and cancer.